Mutational status of <i>TP53</i> defines the efficacy of Wee1 inhibitor AZD1775 in <i>KRAS</i>-mutant non-small cell lung cancer
Bo Mi Ku(Samsung Medical Center), Myung‐Ju Ahn(Samsung Medical Center)
Cited by 40
Related Papers
MDSC subtypes and CD39 expression on CD8 <sup>+</sup> T cells predict the efficacy of anti‐PD‐1 immunotherapy in patients with advanced NSCLC
|European Journal of Immunology|2020|90
Caffeine Inhibits Cell Proliferation and Regulates PKA/GSK3β Pathways in U87MG Human Glioma Cells
|Molecules and Cells|2011|76
Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer
|Investigational New Drugs|2019|50